Epigenomics of Common Diseases
01–04 November 2016
Wellcome Genome Campus, Hinxton, UK
The 6th Epigenomics of Common Diseases conference will bring together
leading scientists from the fields of epigenomics, genetics and
bioinformatics to discuss the latest developments in this fast-moving
Epigenetic variation plays an important role in disease processes and
provides a promising focus for disease prediction, prevention and
treatment. Technological advancements in the past few years have fuelled
a dramatic increase in the scale, breadth and availability of epigenomic
reference data. In addition, novel developments such as single cell
analysis and gene editing present exciting new opportunities.
Associations between epigenetic variation, a variety of risk factors and
the development of many diseases continue to emerge but causality has, in
many instances, not yet been established.
This meeting will focus on epigenomic studies across of a wide range of
common and other diseases including cancer, and will include approaches
from a variety of different disciplines. It will explore technological
and methodological developments and provide a forum to present and
discuss recent advances in epigenomics of relevance to human disease.
The conference will start at approximately 12.30 on Tuesday, 1 November
and close at approximately 14.00 on Friday, 4 November 2016.
Topics will include:
- Epigenomics of disease
- Epigenetics in neuro-psychiatric disorders
- Cancer epigenetics
- Epigenetics of ageing
- Nutritional epigenetics
- Trans-generational epigenetic inheritance
- Computational epigenomics
- Population epigenetics
- Clinical epigenetics
- Single cell epigenetics
- Informatics and technology
Organisers and speakers
Scientific programme committee
Edith Heard Institut Curie, France
Doug Higgs University of Oxford, UK
Caroline Relton University of Bristol, UK
Art Petronis University of Toronto, Canada
Anne Ferguson-Smith University of Cambridge, UK
Oliver Rando UMass Medical School, USA
Schahram Akbarian Icahn School of Medicine at Mount Sinai, USA
Stephan Beck UCL Cancer Institute, UK
Irene Cantone MRC Clinical Science Centre, UK
John Chambers Imperial College London, UK
Bill Cookson Imperial College London, UK
Manel Esteller IDIBELL, Spain
Daniele Fallin Johns Hopkins Bloomberg School of Public Health, USA
Andre Fischer Georg-August-University, Gottingen, Germany
Anna Gloyn University of Oxford, UK
Ivo Gut CNAG-CRG, Spain
Petra Hajkova MRC Clinical Sciences Centre and Imperial College London, UK
Peter Jones Van Andel Research Institute, USA
David Katz Emory University, USA
John Marioni EMBL-EBI, UK
Stefan Mundlos Charité Universitätsmedizin Berlin, Germany
John Pospisilik Max Planck Institute of Immunobiology and Epigenetics, Germany
Wolf Reik Babraham Institute, UK
David Ruff Fluidigm Corporation, USA
Julian Sale MRC Laboratory of Molecular Biology, UK
Nicole Soranzo Wellcome Trust Sanger Institute, UK
Francois Spitz Institut Pasteur, France
Laura Hubbard Wellcome Genome Campus, UK
How to apply
|Student||On site twin accommodation – SOLD OUT||£523.00|
|Student||On site single accommodation – SOLD OUT||£617.00|
|Academic||On site twin accommodation – SOLD OUT||£623.00|
|Academic||On site single accommodation – SOLD OUT||£717.00|
|Commercial||On site twin accommodation – SOLD OUT||£723.00|
|Commercial||On site single accommodation – SOLD OUT||£817.00|
The registration fee includes entrance to the lectures and poster
sessions, an abstract book, meals (lunch and dinner) and refreshments
during the conference. Breakfast will be provided for delegates who have
Registration deadline: Closed
Accommodation is provided for the nights of 1, 2 and 3 November 2016.
Please note: there is limited onsite accommodation and this will be
allocated on a first-come, first-served basis. Therefore, early
registration is recommended.
If you wish to book onsite accommodation either side of the conference
dates, please contact the Conference Centre directly.
PLEASE NOTE: Onsite accommodation has now sold out.
Please contact the conference organiser to be added to the waitlist and
receive alternative accommodation suggestions.
Contact the conference organiser if you require a letter to support a
travel visa application. Please note: letters will only be provided to
Non-European Economic Area or Swiss nationals may be required to have a
visa to enter the UK.
Early application is strongly advised, as this process can take 6-8 weeks
Please visit the following websites for further information:
UK Border Agency website: www.ukba.homeoffice.gov.uk/visas-immigration/
Information for general visitors and business visitors: www.ukba.homeoffice.gov.uk/visas-immigration/visiting/business/business-activities/
A limited number of registration bursaries are available for PhD students
to attend this conference (up to 50% of the registration fee) from
Wellcome Genome Campus Scientific Conferences.
The following documents will need to be provided:
- Covering letter
- Letter from supervisor
To apply, please contact the conference organiser.
Bursary deadline: Closed
We welcome abstracts from all areas relevant to the main themes of the
meeting, for both oral and poster presentations. Several oral
presentations will be chosen from the abstracts submitted.
Abstracts will only be considered from registered delegates. Please use our online abstract submission system and follow the instructions given to ensure your abstract is submitted correctly. All abstracts must be submitted by the deadline. If you are intending to submit more than one abstract, please contact the conference organiser prior to registration.
The scientific programme committee will assess your abstract after the
deadline has passed and you will be notified whether you have been
selected for an oral or poster presentation.
Poster boards onsite will accommodate 118 cm high by 84 cm wide (A0-
portrait) of printed material. Accepted abstracts will appear in the
conference programme book and poster boards will be allocated at the
Abstract deadline: Closed
Abstract guidelines can be viewed here.